Washington: US to investigate reports of blood clotting accumulations of & lsquo; & lsquo; temporarily stop & rsquo; & rsquo; Johnson & Johnson’s one-dose Kovid-19 vaccine. Is recommended.
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said in a joint statement on Tuesday that they are investigating a case of blood clotting in six women a few days after vaccination.
The statement states that a blood clot with a decreased number of platelets in the blood is commonly used in its (blood clots) treatment for & lsquo; heparin & rsquo; (Medicine) may prove to be dangerous.
The statement said that more than 68 lakh doses of this vaccine have been given in the US, most of which have not seen any kind of side effect. US federal distribution centers, including mass vaccination centers, will temporarily stop Johnson & Johnson’s vaccine doses, and provinces and other vaccinated parties are expected to comply. However, two other vaccines, Modarena and Pfizer, will not apply this temporary restriction.
The CDC Advisory Committee on Immunization will meet on Wednesday, in which matters will be discussed. Additionally, the FDA has also started an investigation into blood clotting and decreased platelet counts.
Dr. Annie Suchat, Principal Deputy Director of the CDC and Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research, said in a joint statement, “Until the process is complete, we will temporarily stop the use of this vaccine.” Are recommended. & rsquo; & rsquo; They have suggested that people who are experiencing headaches, abdominal pain, leg pain, or rapid breathing within three weeks after receiving the Johnson & Johnson vaccine should contact their healthcare provider. . The vaccine was granted emergency use by the FDA at the end of February.
It is noteworthy that concerns about blood clotting have so far focused only on the AstraZeneca vaccine, which has not yet been allowed to be used in the US. However, last week European regulators said that they had detected a possible association between vaccine doses and a very rare type of blood clot, which are produced in young people with low platelet counts. .
It is noteworthy that Johnson & Johnson and AstraZeneca vaccines are made from the same technology. Shares of the company fell three percent following the announcement of a recommendation for a temporary moratorium on Johnson & Johnson vaccines.